Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 11-20 of 474 (Search time: 0.004 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy malesWu, T.; Rayner, C.; Watson, L.; Jones, K.; Horowitz, M.; Little, T.
2012Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese menBrennan, I.; Luscombe-Marsh, N.; Seimon, R.; Otto, B.; Horowitz, M.; Wishart, J.; Feinle-Bisset, C.
2012Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetesHorowitz, M.; Flint, A.; Jones, K.; Hindsberger, C.; Rasmussen, M.; Kapitza, C.; Doran, S.; Jax, T.; Zdravkovic, M.; Chapman, I.
2014Postprandial hypotension: systematic reviewTrahair, L.; Horowitz, M.; Jones, K.
2010Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatmentsTesfaye, S.; Boulton, A.; Dyck, P.; Freeman, R.; Horowitz, M.; Kempler, P.; Lauria, G.; Malik, R.; Spallone, V.; Vinik, A.; Bernardi, L.; Valensi, P.; Frontoni, S.
2009Relationship between symptoms and dietary patterns in patients with functional dyspepsiaPilichiewicz, A.; Horowitz, M.; Holtmann, G.; Talley, N.; Feinle-Bisset, C.
2008A high-fat diet raises fasting plasma CCK, but does not affect upper gut motility, PYY and ghrelin, or energy intake during CCK-8 infusion in lean menLittle, T.; Feltrin, K.; Horowitz, M.; Meyer, J.; Wishart, J.; Chapman, I.; Feinle-Bisset, C.
2013Glucagon-like peptides 1 and 2 in health and disease: A reviewMarathe, C.; Rayner, C.; Jones, K.; Horowitz, M.
2013Effects of intraduodenal lipid and protein on gut motility and hormone release, glycemia, appetite, and energy intake in lean menHutchison, A.; Luscombe-Marsh, N.; Saies, A.; Little, T.; Standfield, S.; Horowitz, M.; Feinle-Bisset, C.
2014Effects of sitagliptin on glycemia, incretin hormones, and antropyloroduodenal motility in response to intraduodenal glucose infusion in healthy lean and obese humans and patients with type 2 diabetes treated with or without metforminWu, T.; Ma, J.; Bound, M.; Checklin, H.; Deacon, C.; Jones, K.; Horowitz, M.; Rayner, C.